onr:"swepub:oai:DiVA.org:uu-55620"
Search: onr:"swepub:oai:DiVA.org:uu-55620" > Clinical symptoms, ...
- 1 of 1
- Previous record
- Next record
- To hitlist
Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids
-
- Granberg, Dan (author)
- Karolinska Institutet,Uppsala universitet,Institutionen för medicinska vetenskaper
-
- Wilander, Erik (author)
- Uppsala universitet,Institutionen för genetik och patologi
-
- Stridsberg, Mats (author)
- Uppsala universitet,Institutionen för medicinska vetenskaper,Clinical Chemistry
- show more...
- Granerus, Göran (author)
- show less...
- (creator_code:org_t)
- BMJ, 1998
- 1998
- English.
- In: Gut. - : BMJ. - 0017-5749 .- 1468-3288. ; 43:2, s. 223-228
- Journal article (peer-reviewed)
Abstract
Subject headings
Close
- BACKGROUND: Type 1 gastric carcinoids are associated with hypergastrinaemia and chronic atrophic gastritis, type 2 occur in patients with multiple endocrine neoplasia type 1 combined with Zollinger-Ellison syndrome, and type 3 lack any relation to hypergastrinaemia. Type 1 tumours are usually benign whereas type 3 are highly malignant. AIMS: To identify possible tumour markers in patients with gastric carcinoids. PATIENTS/METHOD: Nine patients with type 1, one with type 2, and five with type 3 were evaluated with regard to symptoms, hormone profile, and prognosis. RESULTS: Plasma chromogranin A was increased in all patients but was higher (p < 0.01) in those with type 3 than those with type 1 carcinoids. All patients with type 3 carcinoids died from metastatic disease, but none of the type 1 patients died as a result of their tumours. One type 1 patient with a solitary liver metastasis received interferon alpha and octreotide treatment. Nine months later, the metastasis was no longer detectable. She is still alive eight years after diagnosis, without recurrent disease. This represents the only reported case of foregut carcinoid with an unresectable liver metastasis that seems to be have been cured by biotherapy. CONCLUSIONS: Plasma chromogranin A appears to be a valuable tumour marker for all types of gastric carcinoid. Combination therapy with interferon alpha and octreotide may be beneficial in patients with metastasising type 1 gastric carcinoids.
Keyword
- gastric carcinoids
- chromogranin
- histamine
- interferon
- octreotide
- MEDICINE
- MEDICIN
Publication and Content Type
- ref (subject category)
- art (subject category)
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Granberg, Dan
- Wilander, Erik
- Stridsberg, Mats
- Granerus, Göran
- Skogseid, Britt
- Öberg, Kjell
- Articles in the publication
- Gut
- By the university
- Uppsala University
- Karolinska Institutet
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
